NovaBay Pharmaceuticals (NBY) PT Raised to $3.75 at Ascendiant Capital

April 5, 2021 4:22 AM EDT
Get Alerts NBY Hot Sheet
Price: $0.72 -6.49%

Rating Summary:
    2 Buy, 4 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo raised the price target on NovaBay Pharmaceuticals (NYSE: NBY) to $3.75 (from $3.50) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change